Sanctuary Advisors LLC Takes $3.04 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Sanctuary Advisors LLC purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 34,250 shares of the medical device company's stock, valued at approximately $3,043,000.

Other hedge funds have also recently bought and sold shares of the company. LRI Investments LLC lifted its holdings in shares of Cooper Companies by 4.5% during the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company's stock worth $227,000 after acquiring an additional 112 shares during the period. Commonwealth Equity Services LLC lifted its position in Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company's stock worth $1,362,000 after acquiring an additional 118 shares in the last quarter. First Horizon Advisors Inc. grew its holdings in Cooper Companies by 4.8% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company's stock valued at $236,000 after purchasing an additional 125 shares in the last quarter. American International Group Inc. increased its position in shares of Cooper Companies by 1.0% during the fourth quarter. American International Group Inc. now owns 13,229 shares of the medical device company's stock worth $5,006,000 after acquiring an additional 137 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV boosted its holdings in Cooper Companies by 18.7% in the second quarter. Massmutual Trust Co. FSB ADV now owns 996 shares of the medical device company's stock valued at $87,000 after purchasing an additional 157 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Agostino Ricupati sold 1,601 shares of the company's stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Daniel G. Mcbride sold 114,992 shares of the company's stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares of the company's stock, valued at $4,714,534.08. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 256,373 shares of company stock worth $27,637,427. Corporate insiders own 2.00% of the company's stock.

Cooper Companies Price Performance

Shares of COO traded down $0.43 during midday trading on Monday, reaching $105.49. The stock had a trading volume of 1,149,612 shares, compared to its average volume of 1,122,651. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The company has a market capitalization of $21.01 billion, a P/E ratio of 62.31, a P/E/G ratio of 2.63 and a beta of 0.98. The firm's 50 day moving average price is $101.43 and its 200-day moving average price is $95.95. The Cooper Companies, Inc. has a 52 week low of $75.93 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. During the same period in the prior year, the business earned $0.84 earnings per share. The business's quarterly revenue was up 7.8% on a year-over-year basis. On average, analysts forecast that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have commented on COO shares. Jefferies Financial Group upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and increased their price objective for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Stifel Nicolaus reiterated a "buy" rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Wells Fargo & Company upped their price objective on Cooper Companies from $110.00 to $115.00 and gave the company an "overweight" rating in a research note on Thursday, August 29th. Morgan Stanley lifted their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an "equal weight" rating in a research report on Tuesday, September 10th. Finally, Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and an average target price of $115.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.